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ABSTRACT 
 
Background: Bone allografts are a useful and sometimes indispensable tool for the surgeon to 
repair bone defects. Microbial contamination is a major reason for discarding allografts from 
bone banks. To improve the number of safe allografts, we suggest chemical cleaning of the grafts 
followed by antibiotic impregnation. 
 
Objectives: Comparison of two chemical cleaning processes for bone allografts aiming for 
antibiotic impregnation and consequently delivery rates in vitro.  
 
Materials and Methods: Bone chips of 5-10 mm were prepared from human femoral heads. 
Two cleaning methods (cleaning A and cleaning B) based on solutions containing hydrogen 
peroxide, paracetic acid, ethanol and biological detergent were carried out and compared.  After 
the cleaning processes, the bone chips were impregnated with gentamicin. Bacillus subtilis 
bioassay was used to determine the gentamicin release after intervals of 1, 2, 3, 4, 5, 6 and 7 
days. Differences were compared with non-parametric Mann-Whitney U-tests.  
 
Results: The zones of inhibition obtained from the bone grafts cleaned with both cleaning 
processes were similar between the groups. The concentration of the released antibiotic was 
decreasing gradually over time, following a similar pattern for both groups.  
 
Conclusions: The cleaning procedure A as well as the cleaning procedure B for bone allografts 
allowed the impregnation with gentamicin powder in the same concentrations in both groups. 
The delivery of gentamicin was similar for both groups. Both cleaning procedures were easy to 
be carried out, making them suitable for routine use at the bone banks. 
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INTRODUCTION 
Bone allografts are a useful and sometimes indispensable tool for the orthopaedic surgeon 
to repair bone defects and to improve function.  Bone grafting is indicated for joint 
reconstruction, repair of congenital defects of the skeleton or reconstructive procedures after 
trauma and diseases (Hinsenkamp et al. 2012; Putzer et al. 2011). Allografts have some 
advantages over autograft bone, e.g. avoidance of the donor site morbidity and availability 
(Barbour and King  2003; Butler et al. 2005; Haimi et al. 2008). By establishing tissue banks, the 
use of allografts has become widely accepted. Therefore, tissue banks must optimize procedures 
to increase the number of available safe allografts. Contamination is a major reason for 
discarding allografts (Deijkers et al. 1997; Schubert et al. 2012).  
 
The need to ensure maximum safety has lead to a search for different sterilization 
methods for bone allografts. The most commonly used methods are chemical sterilization and 
beta and gamma irradiation (Vastel et al. 2004; Grieb et al. 2005). Chemical cleaning of bone 
allografts provides an additional level of safety but it is important not to jeopardize the graft by 
cleaning it. Commonly used chemical methods employ aqueous solutions of detergents, 
surfactants, peroxides, organic solvents, acids and alcohol. These methods can be used in 
combination with mechanical methods such as pressure or vacuum, ultrasonic baths, agitation or 
centrifugation to facilitate the cleaning (DePaula et al. 2005).  
 
Surgery with bone allografts is more complex and time-consuming than, for example, 
primary hip surgery, which may contribute to a higher infection rate with percentages ranging 
from 2.0% to 2.5% (Parvizi et al. 2008; Parvizi et al. 2007; Blom et al. 2003). The impaction 
procedure for bone allografts creates an avascular area where local circulation is disrupted. If 
infections arise, this may prevent systemically administered antibiotics from reaching the 
infected bone (Isefuku et al. 2003; Mathijssen et al. 2010). In addition, when the bacteria, which 
colonized the implant surfaces, produce a biofilm they become more resistant against antibiotics 
(Coraça-Huber et al. 2012). Bone cements containing antibiotics were developed to solve this 
problem. These cements may serve as drug delivery system and prophylaxis against infections as 
they make it possible to achieve higher local drug concentrations. However, controversy exists 
on the efficacy of the antibiotic-loaded cements. Probably 90% of the antibiotics contained in the 
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cements are never released. Only when cracks are formed in the cement layer will a small, sub-
inhibitory amount of antibiotic be released into the surrounding tissue. This release can continue 
for years, potentially inducing bacterial resistance (van de Belt et al. 2001; Winkler et al. 2006).  
In addition, the formation of cracks in the cements reduces the stability of the cemented implant 
leading to prosthetic loosening and related complications (Choi et al. 2010).  
 
An ideal antibiotic carrier for prevention and treatment of periprosthetic joint infections 
should be able to carry a substance with bactericidal activity against most pathogens. It should be 
able to provide and sustain high concentrations of the antibiotic at the surgical site without local 
or systemic toxicity. In addition, it should improve osteoconductivity and osteoinductivity, 
supporting the bone healing without further surgery (Saraf et al. 2010). Several studies have 
shown that morselized bone allografts can act as a carrier for antibiotics either by impregnating 
the bone grafts with antibiotic solutions (Witsø et al. 2005; Winkler et al. 2000) or by mixing 
them with antibiotic powders (Buttaro et al. 2005; Buttaro et al. 2003).   
 
 To increase the safety of bone allografts as well as to obtain an efficient antibiotic carrier, 
why not impregnate the bone allografts with an antibiotic after chemical cleaning procedures? 
Some studies have been carried out with morselized bone grafts without chemical sterilization 
which were impregnated with antibiotic substances for local delivery (Buttaro et al. 2005; 
Mathijssen et al. 2010). However, only few studies investigate the delivery rate of antibiotic 
from chemically sterilized bone grafts (Winkler et al. 2000).  
 
 In this study, we compared two chemical cleaning processes for human bone allografts 
followed by gentamicin impregnation. Our objective was to determine the cleaning process 
which allows higher levels of antibiotic impregnation and consequently higher delivery rate in 
vitro.  
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MATERIALS AND METHODS 
 
Bone Allografts 
Femoral heads were removed during total hip replacement surgery following femoral 
head osteotomy and sliced in the horizontal plane under sterile conditions. Throughout the 
procedure the bone was rinsed with sterile 0.9% saline to prevent damage by the high 
temperatures during drilling.  For the experiments, cortical and cartilage tissues were removed 
from the femoral heads with a bone saw.  Bone chips (BCh) with a size of 5-10 mm were 
prepared from the spongious tissue using a bone mill (Noviomagus Bone Mill, Spierings 
Medische Techniek BV, Nijmegen, The Netherlands). All morselized bone was carefully mixed 
to achieve homogenous bone quality and to minimize differences due to patient specific bone 
characteristics. The femoral heads were fresh frozen at -80°C. All patients approved previously 
the use of the specimens in this study. Ten grams of BCh were divided in two groups: 5 g 
divided in 5 tubes for cleaning process A and 5 g divided in 5 tubes for cleaning B.  
   
Cleaning Process A  
 This procedure was based on the process used by Haimi and collaborators (Haimi et al. 
2008). An amount of 1g BCh was placed in 15 ml Falcon tubes. Five tubes containing 1g of BCh 
each were used for this cleaning process. Cleaning process A consists of 12 successive steps 
(Figure 1). For the first step, 3 ml of sterile distilled water was added in each tube after which 
the samples were sonicated in an ultrasonic bath (Bandelin electronic GmbH & Co. KG, Berlin, 
Germany) for 15 min at 45-50°C. The samples were washed and agitated (Tube Rotator Stuart
®
 
SB3, Staffordshire, UK) for 30 min on 40 rpm at 37°C followed by centrifugation (1900g) for 15 
min at room temperature (RT). The samples were washed and agitated (40 rpm) for 10 min at 
37°C. After 10 min, the samples were centrifuged (1900g) for 15 min at RT, washed and agitated 
(40 rpm) for 10 min at 37°C, followed by centrifugation (1900g) for 15 min at RT. The washing, 
agitation and centrifugation steps were repeated once. The washing solution (distilled water) was 
replaced before each repetition. The next step after the last centrifugation was to remove the 
distilled water and add a 1:1 solution of 3% hydrogen peroxide (Sigma-Aldrich, Schnelldorf, 
Germany) with 0.02% paracetic acid (Sigma-Aldrich, Schnelldorf, Germany) after which the 
samples were sonicated for 10 min at RT. After 10 min the solution was removed and 70% 
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ethanol was added. The tubes were sonicated for 10 min at 45-50°C. The ethanol was removed 
and the samples were washed and agitated in distilled water for 20 min at 37°C. At the end of the 
process the washing solution was removed and the samples stored in a refrigerator at 3-4°C 
before the antibiotic impregnation process. These procedures were carried out in triplicate. 
 
Cleaning Process B 
 This process was based on a procedure used by DePaula and collaborators (DePaula et al. 
2005).  An amount of 1g BCh was placed in 15 ml Falcon tubes. Five tubes containing 1g of 
BCh each were used for this cleaning process. The cleaning process B consists of 10 successive 
steps (Figure 1). For the first step 3 ml of 1% Triton X-100 (Sigma-Aldrich, Schnelldorf, 
Germany) were added in each tube and the samples were sonicated for 30 min at 45-50°C. After 
30 min the Triton X-100 solution was removed and 3 ml of sterile distilled water were added. 
The samples were sonicated for 5 min at 45-50°C. After 5 min the distilled water was replaced 
with sterile distilled water and the samples were sonicated for an additional 10 min at 40-45°C. 
For the next step, the solution was removed from the tubes and 14 ml of 3% hydrogen peroxide 
(Sigma-Aldrich, Schnelldorf, Germany) solution was added. The samples were sonicated for 60 
min at RT. After 60 min, the hydrogen peroxide was removed and the sterile distilled water was 
added to the tubes. The samples were sonicated for additional 5 min at RT. The solution was 
renewed and the procedure was repeated for 5 more minutes. The solution was removed from the 
tubes and new sterile distilled water was added. At this time the samples were sonicated for 30 
min at RT. After 30 min the solution was removed and 70% ethanol was added in each tube and 
the samples were sonicated for 60 min at RT. After 60 min the ethanol was removed and sterile 
distilled water was added in the tubes. The samples were sonicated for 10 min at RT and after 
renewing the distilled water, sonicated for an additional 30 min at RT. At the end of the process 
the washing solution was removed and the samples stored in a refrigerator at 3-4°C before the 
antibiotic impregnation process. These procedures were carried out in triplicate. 
 
Antibiotic Impregnation 
 For the BCh impregnation, gentamicin was chosen as the antibiotic substance (Swieringa 
et al. 2008; Nadrah and Strle 2011).  After cleaning, 8 g of gentamicin sulfate powder 
(equivalent 5 g of gentamicin basis), (SERVA GmbH, Heidelberg, Germany) was added in each 
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tube containing 1 g of bone chips and mechanically mixed with the help of a sterile spatula. The 
samples were stored at RT for 1 h prior the release assay.   
 
Antibiotic Release Assay 
The release of gentamicin from impregnated BCh was carried out by using phosphate-
buffered saline (PBS) pH 7.4 (Sigma-Aldrich, Schnelldorf, Germany). After 1 h at RT, 3 ml of 
PBS was added into each tube. The tubes were vortexed for 1 min and placed on a rocking table 
(Rocky
®
 Biometra, Goettingen, Germany) at 37°C to simulate the tissular conditions. After 1, 2, 
3, 4, 5, 6 and 7 days the elution medium was completely removed and fresh PBS was added. The 
elution was vortexed for 1 min and stored in Falcon tubes at -20°C.  
 
Bacillus subtilis Assay 
The antibiotic delivered was determined after each interval with a conventional 
microbiological agar diffusion assay with Bacillus subtilis as the indicator strain (Merck KGaA, 
Germany in Test Agar pH 8.0 Merck KGaA, Germany) (Stevens et al. 2005).  For this purpose, a 
standard curve was created with known concentrations of the gentamicin sulfate (0.00001, 
0.0001, 0.001, 0.01, 0.1, 1, and 10 mg/ml). Using a 6 mm diameter metal punch a hole was made 
at the center of each B. subtilis agar plates where 50 µl of each concentration were added. The 
plates containing the samples were incubated for 24 h at 37°C. After the incubation period, the 
zones of inhibition were measured on each plate with a ruler and a standard curve was obtained 
for future comparison with the measurements obtained from drug release tests.  
After the intervals of 1 to 7 days, 50 µl of each elution medium were added to B. subtilis 
agar plates following the same procedures carried out for the standard curve obtainment. The 
plates containing the samples were incubated for 24 h at 37°C. After the incubation, the zones of 
inhibition were measured from each plate with a ruler.  Logarithmic regressions of the standard 
concentration curve were calculated to predict the concentrations of the eluted medium after each 
delivery interval.  
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Statistical Analysis 
 Non-parametric Mann-Whitney U-tests were used to find statistically significant 
differences between the delivery rates of gentamicin after each interval, also taking into 
consideration both cleaning processes. SPSS 17.0 (IBM, Chicago, Illinois) was used for the 
statistical analysis. 
 
RESULTS 
 
Zone of inhibition obtained with B. subtilis bioassay   
 The zones of inhibition, obtained by carrying out the B. subtilis bioassay from the BCh 
cleaned by the process and A and by process B, were similar in both groups. Both groups had an 
average zone of inhibition of 4.2 cm at the first day which had been reduced to an average of 3.0 
cm by the last day (Figure 2).  
 
Comparison of gentamicin release rate between cleaning processes 
The gentamicin release from the BCh was similar for both groups. The concentration of 
gentamicin sulfate released at the first day was of 0.855 ± 0.130 mg/ml (mean ± SD) decreasing 
to 0.312 ± 0.101 mg/ml at the second day regardless of the cleaning process. The release 
concentration was decreasing gradually over the periods with a similar behaviour for both groups 
with a measured concentration of 0.020 ± 0.006 mg/ml. A higher concentration of gentamicin 
sulfate was detected from BCh after cleaning A in comparison with BCh after cleaning B but the 
difference was not statistically significant (p=0.08) (Figure 3).   
 
 
 
 
 
 
 
 
 
9 
 
DISCUSSION AND CONCLUSIONS 
 
The goal of this study was to compare two chemical cleaning processes for human bone 
allografts followed by gentamicin impregnation. Our objective was to determine a cleaning 
process which allows higher levels of antibiotic impregnation and consequently higher delivery 
rates in vitro.  
 
During the processing of the bone allografts in this study, the femur heads were submitted 
to tissue debridement where muscle, fat and cartilage tissue was mechanically removed, followed 
by chemical cleaning. Two different processes for chemical cleaning were used, based on soaks 
with hydrogen peroxide, paracetic acid, ethanol and detergents. After the cleaning process, the 
bone allografts were impregnated with gentamicin sulfate. It is believed that cleaning the bone to 
remove fat, bone marrow and soft tissue makes it easier for the solution to penetrate through the 
canaliculi of the bone tissue, increasing the surface available for antibiotic adsorption (Winkler et 
al. 2000). However, is important to highlight that cleaning processes for bone allografts improve 
the safety of the samples but can also decrease the osteogenic properties of the same. The 
optimal bone allograft or bone substitute should provide structural strength, be osteoconductive 
(provide structure for the attachment and growth of cells), osteoinductive (contain active factors 
like hormones which stimulate cell migration and differentiation), osteogenic (contain cells from 
osteogenic linage) and biocompatible.  Bormann and collaborators (2010) tested the 
osteoinductive potential of bone allografts after different processes and concluded that 
osteoinductive factors can be present even after chemical cleaning. Nevertheless, the authors 
identified the osteoinductive factors by ELISA which detects not only active but also inactive 
growth factors (Bormann et al. 2010). To ensure the osteoinductive potential of bone allografts 
after chemical cleaning processes we suggest further studies with cleaned allografts for the 
bioactivity of these factors.  
 
The cleaning process A used in this study was based on a procedure used by Haimi and 
collaborators (2008). This process involves the use of distilled water, hydrogen peroxide, 
paracetic acid and ethanol solutions. The samples are cleaned with the help of ultrasonic baths, 
agitators and centrifuge. The bactericidal, fungicidal, virucidal and sporicidal effects of paracetic 
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acid are well known (Pruss et al. 1999). The addition of ethanol after the treatment with paracetic 
acid reduces the surface tension. Negative pressure removes the gas vesicles, which prevent 
complete tissue penetration of the sterilizing medium (Pruss et al. 2003). Hydrogen peroxide was 
also involved in the cleaning process B, as well as ethanol and biological detergent for fat 
removal. DePaula and collaborators also affirm that hydrogen peroxide has bactericidal effects; 
however, it can decrease the osteoinductivity of bone allografts after 5 h of treatment. In 
accordance with DePaula, we chose to treat the bone allografts in our study with hydrogen 
peroxide for 1 h, thus preventing the osteoinductivity loss of the grafts (DePaula et al. 2005). In 
addition, the two cleaning processes used in this study are easy to be carried out, making them 
suitable for routine use at the bone bank.  
 
After the cleaning processes, the bone allografts were impregnated with gentamicin 
powder. The safety of the bone grafts is crucial for a successful procedure as well as the 
prevention of local infections during surgery.  Antibiotic impregnation of allografts can reduce 
the infection rates in surgical procedures which employ them. The chemical cleaning of bone 
allografts improves the safety by eliminating contaminating factors from the samples. We 
believe that both processes in combination can help increasing the safety of bone allografts in 
general. We chose gentamicin for the impregnation of the samples since it usually is indicated 
for treatment of periprosthetic joint infections (Swieringa et al. 2008; Nadrah and Strle 2011). In 
addition, the use of antibiotic-impregnated cancellous bone from all origin, and not only femoral 
heads, might be an alternative or supplement to antibiotic-containing bone cements. It can be 
used in revisions of aseptic and septic loosened hip and knee prostheses. In a clinic study on two-
stage revision of 30 total hip arthroplasties, the reinfection rate was 3% when using bone 
allografts supplemented with antibiotics (Buttaro et al. 2005). Besides revision prosthetic 
surgery, antibiotic-containing allografts could be used when grafting non-healed fractures, in 
particular infected pseudoarthroses (Witsø 2007).  It is important to highlight that until now no 
studies describe the antibiotic resistance rates after using such impregnated bone allografts. To 
answer this question, further studies should be carried out.  
 
We chose to manually mix the samples with the powder to impregnate the bone grafts 
with the antibiotic. This is a relatively easy procedure which could be suitable for an operating 
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room where the grafts could be mixed with antibiotic drugs during surgery. Some authors first 
dilute the antibiotic powder in a saline solution and then soak the bone grafts in this solution, 
storing them for weeks or months before use (Witsø et al. 2005; Winkler et al. 2000). We believe 
that this is an efficient method for bone chips impregnation since the tissue would act as a 
sponge absorbing the solution. According to these authors, this procedure could also be an 
alternative for long-therm storage of the grafts with antibiotic solutions. However, according to 
Sorger et al (2001), the preservation of the grafts for up to 100 hours in an antibiotic solution 
might influence the mechanical stability of the bone (Sorger et al. 2001). Based on Parrish 
(1973) and Witsø and collaborators (2005), mechanical testing of osteochondral and structural 
allografts impregnated with antibiotics in solutions should be performed before this option is 
taken into clinical use (Parrish 1973; Witsø et al. 2005).  
 
After the impregnation, the delivery rate of the gentamicin was evaluated comparing 
process A and process B. The antibiotic delivered was determined after each interval by using a 
conventional microbiologic agar diffusion assay with Bacillus subtilis as the indicator strain 
(Stevens et al. 2005). The measurement of the zones of inhibition and the predicted concentration 
obtained after each interval showed a statistically similar delivery rate of gentamicin in both 
groups. Taking into consideration that a standard-length hip reconstruction typically requires 
about 100 g of bone chips (Steele RG 2010), once impregnated with gentamicin at the same rate 
used in this study, the locally deliver rate could reach 80 mg/mL after 24 h to 2 mg/mL after 7 
days. This is not a high concentration for local antibiotic therapy. Other studies showed that 
higher concentrations can be achieved by using bone cements and gentamicin impregnated-beads 
(Springer et al. 2004). However, is important to remember that aminoglycoside nephrotoxicity 
occurs in 10%-15% of patients with serum concentrations of gentamicin in the range of 0.9-2 
mg/l (detectable for example in patients which received around 200-400 gentamicin-PMMA 
beads). To clarify this comparison, each gentamicin-PMMA bead normally contains 7.5 mg of 
gentamicin sulfate (de Klaver et al. 2012; Matzke et al. 1983). As the aim of this study was the 
comparison of the delivery rate between bone grafts cleaned with different processes, we affirm 
that the concentrations used are not crucial but the delivery behaviour along the evaluated 
periods is. The gentamicin concentrations for bone graft impregnation can be increased in future 
studies when the objective is to achieve higher delivery rates.  
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In conclusion, we can affirm that both cleaning procedures for bone allografts allowed the 
impregnation of gentamicin powder in the same concentrations. The delivery of gentamicin was 
similar in both groups. Both cleaning processes were easy to be carried out making them suitable 
for routine use at bone banks. We suggest further studies with cleaned allografts for the 
bioactivity of osteoinductive factors and for impregnation and local delivery of higher antibiotic 
concentrations.  
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Figure legends: 
 
Fig. 1 - Flowchart of the cleaning process A and cleaning process B. 
 
Fig. 2 – Zone of inhibition measured from B. subtilis bioassay for gentamicin concentration 
obtained from BCh after cleaning process A and cleaning process B.  
 
Fig. 3 – In vitro release of gentamicin from cleaned BCh during the period of 1 to 7 days. 
Comparison between cleaning process A and cleaning process B. Mann-Whitney U-test (P ≤ 
0.05).  
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